PINION JOHN RICHARD (See Remarks) sold 9.0% of their position (4.50K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $299.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2022ACC: 0001209191-22-015823
Officer· See Remarks
Since Mar 2026
+34.40K
Net shares
Net buyer
$299.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
38.90K acquired · 4.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−4.50K
Price / share
$66.62
Trade value
$299.66K
% of position
9.0%
3/1/2022
49.76K→45.27K
Common Stock
Direct
Shares
+14K
Price / share
—
Trade value
—
% of position
30.9%
3/1/2022
45.27K→59.27K
Total
Net shares
+9.50K
Net value
-$299.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2022 | S · Sale | −4.50K | $66.62 | $299.66K | 9.0% | 49.76K | 45.27K |
| Common Stock Direct | 3/1/2022 | A · Award | +14K | — | — | 30.9% | 45.27K | 59.27K |
| Total | +9.50K | -$299.66K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
24.90K shares
Shares
+24.90K
Strike price
67.37
Held after
24.90K
Exercisable
—
3/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock24.90K shares | 3/1/2022 | A · Award | +24.90K | 67.37 | — | 24.90K |